Cannabis Market demand expands as medical legalization and regulated adult-use programs reshape global supply and investment

VANCOUVER, British Columbia, July 14, 2026 - The global Cannabis market, valued at USD 42.86 Billion in 2025, is expected to reach USD 161.74 Billion by 2035, reflecting a revenue CAGR of 14.2% during the forecast period. Rising acceptance of cannabis for medical applications and the continued expansion of regulated adult-use markets are supporting long-term demand across multiple regions. Governments are also introducing clearer regulatory frameworks for cultivation, processing, and retail distribution. According to the World Health Organization (WHO), access to evidence-based treatments for chronic pain, epilepsy, and other medical conditions continues to receive increasing attention, while regulatory reforms in countries such as Canada, Germany, and several U.S. states are expanding legal access to cannabis-based products.

Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/98

Demand is also supported by increasing investments in cultivation technologies, pharmaceutical-grade cannabis production, and product innovation across oils, edibles, beverages, and wellness formulations. Licensed producers are expanding production capacity to meet both domestic consumption and export opportunities where regulations permit. At the same time, improvements in product standardization, laboratory testing, and quality assurance are increasing confidence among healthcare providers and consumers. For instance, in April 2024, Tilray Brands, Canada, expanded its medical cannabis portfolio in Europe following Germany's implementation of new cannabis legislation that simplified patient access and supported broader medical distribution. These developments continue to encourage investment across cultivation, processing, distribution, and retail channels. These are some of the key factors driving revenue growth of the Cannabis market.

However, the market continues to face several constraints. Regulatory requirements differ widely across countries and even within federal systems, creating compliance challenges for producers operating in multiple jurisdictions. Banking restrictions, taxation policies, and limitations on interstate or international trade continue to affect business expansion in several markets. Price compression resulting from increasing cultivation capacity and competition in mature markets is also placing pressure on producer margins. In addition, inconsistent product regulations and advertising restrictions continue to slow market development in emerging economies. These factors are expected to limit Cannabis market growth to some extent over the forecast period.

The medical cannabis segment accounted for the largest share of the market during the base year. Growing physician acceptance, increasing clinical research, and regulatory approvals for treating chronic pain, epilepsy, multiple sclerosis, chemotherapy-induced nausea, and other conditions continue to support demand. Healthcare systems in several countries are gradually integrating cannabis-based therapies under regulated prescription programs, creating stable demand for pharmaceutical-grade products.

The cannabis edibles and infused products segment is expected to register the fastest growth during the forecast period. Consumers are increasingly seeking smoke-free consumption options with standardized dosage and longer-lasting effects. Product innovation across beverages, chocolates, baked goods, and wellness formulations is expanding consumer choice while attracting new users in regulated recreational markets.

Requesting A Customised Report @https://www.emergenresearch.com/request-for-customization/98

North America accounted for the largest share of the global Cannabis market. Canada remains one of the most established regulated cannabis markets following nationwide legalization, while continued legalization across U.S. states supports investment in cultivation, processing, retail operations, and branded consumer products. Companies including Curaleaf Holdings and Green Thumb Industries continue to expand their product portfolios and retail networks as state-level markets mature.

Europe is expected to record steady growth throughout the forecast period. Regulatory reforms supporting medical cannabis prescriptions and controlled adult-use programs are increasing commercial opportunities across the region. Germany's cannabis legislation implemented in 2024 has strengthened patient access and encouraged investment in licensed cultivation and pharmaceutical distribution. Companies including Aurora Cannabis continue to expand their presence through medical cannabis supply agreements across European healthcare markets.

Asia Pacific is expected to register the fastest growth rate over the forecast period. Countries including Thailand and Australia continue to expand regulated medical cannabis programs while increasing investment in cultivation, research, and manufacturing. Australia's Therapeutic Goods Administration (TGA) continues to oversee medical cannabis access through established regulatory pathways, supporting industry development and product quality standards. Growing healthcare awareness and increasing clinical research activities are expected to create additional opportunities across the region.

To Read More About The Report, Visit @https://www.emergenresearch.com/industry-report/cannabis-market

Contact us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +12092086299
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.